Skip to main content
. 2022 Sep 25;11(5):221–236. doi: 10.5501/wjv.v11.i5.221

Figure 2.

Figure 2

Preclinical and clinical trials on intranasal/mucosal coronavirus disease 2019 vaccines. PIV5: Parainfluenza Virus 5; hPIV2: Human parainfluenza virus 2; NDV: Newcastle disease virus; VSV: Vesicular stomatitis virus; LAIV: Live attenuated influenza vaccine; RSV: Respiratory syncytial virus; COVID-19: Coronavirus disease 2019.